Yanhong Gu Selected Research

coniferaldehyde

1/2021

Coniferyl aldehyde alleviates LPS-induced WI-38 cell apoptosis and inflammation injury via JAK2-STAT1 pathway in acute pneumonia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yanhong Gu Research Topics

Disease

39	Neoplasms (Cancer) 01/2022 - 05/2006
18	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 07/2014
12	Colonic Neoplasms (Colon Cancer) 01/2022 - 04/2014
10	Inflammation (Inflammations) 01/2022 - 11/2013
9	Neoplasm Metastasis (Metastasis) 01/2019 - 02/2014
8	Colitis 01/2022 - 10/2012
6	Carcinogenesis 01/2019 - 12/2011
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2015 - 03/2011
5	Stomach Neoplasms (Stomach Cancer) 01/2019 - 05/2009
4	Liposarcoma 02/2015 - 03/2011
3	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 11/2020
3	Kidney Neoplasms (Kidney Cancer) 05/2021 - 02/2009
3	Diarrhea 01/2019 - 07/2014
3	Renal Cell Carcinoma (Grawitz Tumor) 05/2015 - 04/2010
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 06/2014 - 05/2013
2	Bites and Stings (Sting) 01/2022 - 01/2021
2	Pneumonia (Pneumonitis) 01/2021 - 12/2019
2	Leukemia 12/2020 - 04/2014
2	Lymphoma (Lymphomas) 12/2020 - 06/2014
2	Body Weight (Weight, Body) 12/2020 - 06/2014
2	Biliary Tract Neoplasms (Biliary Tract Cancer) 11/2020 - 01/2018
2	Fibrosis (Cirrhosis) 12/2019 - 01/2016
2	Melanoma (Melanoma, Malignant) 06/2019 - 02/2014
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2018 - 06/2013
2	Carcinoma (Carcinomatosis) 01/2018 - 03/2017
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2017 - 01/2011
2	Lung Neoplasms (Lung Cancer) 03/2015 - 01/2013
2	Immune System Diseases (Immune Disorders) 05/2013 - 10/2012
1	Hepatocellular Carcinoma (Hepatoma) 01/2022
1	Wounds and Injuries (Trauma) 01/2022
1	Mucositis 01/2022
1	Myositis (Idiopathic Inflammatory Myopathies) 11/2021

Drug/Important Bio-Agent (IBA)

10	CytokinesIBA 12/2019 - 05/2006
9	Pharmaceutical PreparationsIBA 01/2022 - 01/2013
7	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2013
6	Tyrosine (L-Tyrosine)FDA Link 01/2021 - 10/2012
5	Tyrosine Kinase InhibitorsIBA 01/2022 - 06/2013
5	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022 - 01/2016
5	andrographolideIBA 01/2022 - 06/2014
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 03/2017
5	InflammasomesIBA 12/2019 - 05/2013
4	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2019
4	CateninsIBA 05/2021 - 05/2015
4	apatinibIBA 11/2020 - 01/2019
4	Messenger RNA (mRNA)IBA 11/2020 - 02/2014
4	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 05/2009
3	Irinotecan (Camptosar)FDA LinkGeneric 01/2022 - 12/2015
3	Granzymes (Granzyme)IBA 10/2021 - 01/2017
3	Fluorouracil (Carac)FDA LinkGeneric 10/2021 - 05/2009
3	Interleukin-17 (Interleukin 17)IBA 02/2020 - 11/2013
3	Dextran SulfateIBA 01/2017 - 05/2013
3	Sulfonic AcidsIBA 01/2017 - 10/2012
3	ErbB Receptors (EGF Receptor)IBA 12/2014 - 03/2011
3	icotinibIBA 12/2014 - 06/2013
2	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2022 - 01/2021
2	Immune Checkpoint InhibitorsIBA 01/2022 - 11/2020
2	DiterpenesIBA 01/2022 - 12/2016
2	PhosphoproteinsIBA 01/2022 - 01/2021
2	PhosphopeptidesIBA 01/2022 - 11/2020
2	andrographolide sulfonateIBA 10/2021 - 06/2014
2	Long Noncoding RNAIBA 07/2021 - 01/2019
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 10/2013
2	Pemetrexed (MTA)FDA Link 11/2020 - 08/2015
2	Protein Tyrosine PhosphatasesIBA 01/2020 - 04/2014
2	pembrolizumabIBA 10/2019 - 06/2019
2	Non-Receptor Type 11 Protein Tyrosine PhosphataseIBA 03/2019 - 04/2014
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 01/2018
2	Interleukin-18 (Interleukin 18)IBA 12/2017 - 12/2015
2	Cadherins (E-Cadherin)IBA 03/2017 - 05/2015
2	AzoxymethaneIBA 01/2017 - 06/2014
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2017 - 10/2013
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2016 - 05/2009
2	Phosphotransferases (Kinase)IBA 01/2016 - 02/2014
2	Sunitinib (Sutent)FDA Link 01/2016 - 04/2010
2	Protein Isoforms (Isoforms)IBA 06/2015 - 05/2015
2	Interleukin-15 Receptors (Interleukin 15 Receptor)IBA 05/2015 - 02/2009
2	Interleukin-15 (Interleukin 15)IBA 05/2015 - 02/2009
2	CurcuminIBA 10/2014 - 03/2011
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 07/2014 - 01/2011
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 07/2014 - 03/2011
2	Axitinib (AG 013736)IBA 07/2014 - 02/2014
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 07/2014 - 02/2014
2	Adenosine Triphosphatases (ATPase)IBA 03/2014 - 03/2011
1	anlotinibIBA 01/2022
1	sintilimabIBA 01/2022
1	Toll-Like Receptor 4IBA 01/2022
1	Antisense RNA (Anti-Sense RNA)IBA 01/2022
1	LactonesIBA 01/2022
1	NF-kappa B (NF-kB)IBA 01/2022
1	LipopolysaccharidesIBA 01/2022
1	InterferonsIBA 01/2022
1	Nucleic AcidsIBA 01/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2021

Therapy/Procedure

23	Therapeutics 01/2022 - 04/2010
10	Drug Therapy (Chemotherapy) 10/2021 - 03/2011
7	Immunotherapy 09/2020 - 02/2009
3	Intraperitoneal Injections 12/2020 - 06/2014
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 10/2021 - 01/2013
2	Renal Dialysis (Hemodialysis) 04/2021 - 11/2019
2	Radiotherapy 12/2019 - 12/2011